Related Experiment Video
Updated: Jul 25, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells
D Chauhan1, T Hideshima, S Rosen
1Jerome Lipper Multiple Myeloma Center, Department of Adult Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Smac, a second mitochondria-derived activator of caspases, promotes caspase activation in the cytochrome c (cyto-c)/Apaf-1/caspase-9 pathway. Here, we show that treatment of multiple myeloma (MM) cells with dexamethasone (Dex) triggers the release of Smac from mitochondria to cytosol and activates caspase-9 without concurrent release of cyto-c and Apaf-1 oligomerization. Smac binds to XIAP (an inhibitor of apoptosis protein) and thereby, at least in part, eliminates its inhibitory effect on caspase-9. Interleukin-6, a growth factor for MM, blocks Dex-induced apoptosis and prevents release of Smac. Taken together, these findings demonstrate that Smac plays a functional role in mediating Dex-induced caspase-9 activation and apoptosis in MM cells.
Insights
Smac (second mitochondria-derived activator of caspases) release mediates dexamethasone-induced apoptosis in multiple myeloma cells by activating caspase-9. Interleukin-6 blocks this Smac-dependent pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Smac (second mitochondria-derived activator of caspases) is crucial for caspase activation.
- Dexamethasone (Dex) is a therapeutic agent used in multiple myeloma (MM).
- Interleukin-6 (IL-6) is a key growth factor for MM cells.
Purpose of the Study:
- To investigate the role of Smac in dexamethasone-induced apoptosis in MM cells.
- To elucidate the mechanism of caspase-9 activation by Smac in MM.
- To determine the effect of IL-6 on Smac release and apoptosis in MM.
Main Methods:
- Treatment of MM cells with dexamethasone.
- Mitochondrial and cytosolic fractionation to assess Smac localization.
- Caspase activity assays.
- Western blotting to detect protein oligomerization and interactions.
Main Results:
- Dexamethasone treatment induced Smac release from mitochondria to the cytosol in MM cells.
- Caspase-9 activation occurred independently of cytochrome c release and Apaf-1 oligomerization.
- Smac binding to XIAP (inhibitor of apoptosis protein) reduced XIAP's inhibition of caspase-9.
- Interleukin-6 inhibited dexamethasone-induced apoptosis by preventing Smac release.
Conclusions:
- Smac is a key mediator of dexamethasone-induced apoptosis in multiple myeloma cells.
- Smac facilitates caspase-9 activation through XIAP inhibition, independent of the canonical mitochondrial pathway.
- Interleukin-6 confers resistance to dexamethasone by blocking Smac release, highlighting a potential therapeutic target.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
13:53Flow Cytometric Analysis of Apoptotic Biomarkers in Actinomycin D-Treated SiHa Cervical Cancer Cells
Published on: August 26, 2021
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy